AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Collaboration Targets Three Oncogenic Viruses.(Brief Article)
2001 AUG 8 - (NewsRx.com & NewsRx.net) --
Genencor International, Inc. (GCOR) and Epimmune Inc. (EPMN) announced that the two companies have initiated a 30-month collaboration focused on the development of therapeutic vaccines for three oncogenic viruses.
The companies also announced that Genencor has exclusively licensed Epimmune's epitope and Padre(R) technologies and related intellectual property rights on a worldwide basis for vaccines to treat or prevent hepatitis C (HCV), hepatitis B (HBV), and human papillomavirus (HPV).
Through the collaboration, the companies will develop therapeutic vaccines for HCV, HBV, and HPV.
Epimmune brings epitope discovery and vaccine design technologies, including computer and biochemical-based ...
- Role of therapeutic vaccines for the control of HIV-1 reviewed.
- Newspaper article from: Vaccine Weekly June 2, 2004 700+ words
...review the role of therapeutic vaccines for the control...role for HIV-1 therapeutic vaccines in the era of...Chemotherapy (Role of therapeutic vaccines in the control...was prepared by Vaccine Weekly editors from staff...
- Advances in therapeutic vaccines for neurodegenerative disorders outlined.
- Newspaper article from: Vaccine Weekly March 12, 2003 700+ words
...Research into the development of therapeutic vaccines for neurodegenerative disorders...enemy within: Development of therapeutic vaccines for neurodegenerative disorders...This article was prepared by Vaccine Weekly editors from staff and other...
- Company focuses on therapeutic vaccines, slashes workforce to cut expenses.
- Newspaper article from: Vaccine Weekly July 28, 2004 700+ words
...intensively on its program to develop therapeutic vaccines against cancer and infectious...This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx...
- Collaboration extended on therapeutic vaccines for three oncogenic...
- Newspaper article from: Vaccine Weekly November 27, 2002 700+ words
...preventive drug candidates are designed to protect against disease by teaching the body's immune system to react quickly when exposed to infectious agents. This article was prepared by Vaccine Weekly editors from staff and other reports.
- Will therapeutic vaccines, which have had setbacks, fulfil their promise?
- Newspaper article from: Pharma Marketletter January 30, 2006 700+ words
Therapeutic vaccines have faced numerous setbacks...vaccines dominate the pipeline Therapeutic vaccines are defined as medications that...fact, the analysis shows that therapeutic vaccines development is currently heavily...
- Research and Markets: Therapeutic Vaccines.
- Press release article from: Business Wire August 26, 2004 700+ words
...Ireland -- The Worldwide Market for Therapeutic Vaccines is Estimated to Be $80M in 2004...has announced the addition of Therapeutic Vaccines to their offering. With the worldwide...patients. The worldwide market for therapeutic vaccines is estimated to be$80M in 2004...
- Building Better Therapeutic Vaccines for Chronic Infections:Study Finds Poor T...
- News wire article from: AScribe Health News Service July 1, 2005 700+ words
...increasingly interested in developing therapeutic vaccines. Most Americans are familiar with...vaccines as well as the flu shot. But therapeutic vaccines are designed instead to be administered...such as HIV or hepatitis. These therapeutic vaccines aim to enhance the immune system...
- Therapeutic vaccines target HPV.(Cervical cancer)(Human Papilloma Virus)
- Magazine article from: Chemistry and Industry Carmichael, Helen August 13, 2007 700+ words
...cancer experts say. But progress in therapeutic vaccines offers hope to women with early...some strains of HPV. Meanwhile, therapeutic vaccines would most likely be marketed to...be worth 400-700m [euro]. 'Therapeutic vaccines would represent a very small slice...
- Businessinfo.ws: Therapeutic Vaccines to Be Worth USD 4.3 Bn In 2010.
- Press release article from: Business Wire March 22, 2005 700+ words
...the total global market for therapeutic vaccines was USD 8.1 million in 2004...products easier. However, with therapeutic vaccines, especially those for treating...Because of the innovative nature of therapeutic vaccines, they will be very high-ticket...
- Oxxon completes 15m [pounds sterling] round to fund therapeutic vaccines.
- Newspaper article from: BioWorld International Moran, Nuala April 16, 2003 700+ words
...Oxxon Pharmaccines Ltd., a therapeutic vaccines specialist, reached the upper limit...recognition of the commercial potential of therapeutic vaccines, where the technology is maturing...are now focused on driving our two therapeutic vaccines products to proof of clinical efficacy...
Source: HighBeam Research, Collaboration Targets Three Oncogenic Viruses.(Brief Article)